Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Colorcon
McKesson
Harvard Business School
Johnson and Johnson

Last Updated: March 27, 2023

Almatica Company Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Almatica
International Patents:58
US Patents:9
Tradenames:15
Ingredients:14
NDAs:14

Drugs and US Patents for Almatica

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Almatica MACRODANTIN nitrofurantoin, macrocrystalline CAPSULE;ORAL 016620-003 Approved Prior to Jan 1, 1982 AB RX Yes No See Plans and Pricing See Plans and Pricing
Almatica FLUOXETINE HYDROCHLORIDE fluoxetine hydrochloride TABLET;ORAL 202133-001 Oct 6, 2011 AB RX Yes Yes See Plans and Pricing See Plans and Pricing
Almatica NAPRELAN naproxen sodium TABLET, EXTENDED RELEASE;ORAL 020353-003 Jan 5, 1996 AB RX Yes Yes See Plans and Pricing See Plans and Pricing
Almatica TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 AB RX Yes No See Plans and Pricing See Plans and Pricing
Almatica TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 AB RX Yes Yes See Plans and Pricing See Plans and Pricing
Almatica GRALISE gabapentin TABLET;ORAL 022544-001 Jan 28, 2011 BX RX Yes Yes 8,192,756 See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Almatica

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Almatica TENORMIN atenolol TABLET;ORAL 018240-001 Approved Prior to Jan 1, 1982 3,934,032 See Plans and Pricing
Almatica TENORMIN atenolol TABLET;ORAL 018240-004 Apr 9, 1990 3,934,032 See Plans and Pricing
Almatica GRALISE gabapentin TABLET;ORAL 022544-002 Jan 28, 2011 8,333,992 See Plans and Pricing
Almatica ZESTRIL lisinopril TABLET;ORAL 019777-004 May 19, 1988 4,374,829*PED See Plans and Pricing
Almatica GRALISE gabapentin TABLET;ORAL 022544-002 Jan 28, 2011 6,635,280 See Plans and Pricing
Almatica GRALISE gabapentin TABLET;ORAL 022544-001 Jan 28, 2011 8,252,332 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ALMATICA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Extended-release Tablets 450 mg ➤ Subscribe 2013-02-28
➤ Subscribe Tablets 300 mg and 600 mg ➤ Subscribe 2011-10-31
Premature patent expirations for ALMATICA

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
See Plans and Pricing See Plans and Pricing

Supplementary Protection Certificates for Almatica Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2316456 CA 2017 00062 Denmark See Plans and Pricing PRODUCT NAME: NALTREXON ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER NALTREXONHYDROCHLORID, OG BUPROPION ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF, ISAER BUPROPIONHYDROCHLORID; REG. NO/DATE: EU/1/14/988 20150330
0984957 PA2011005,C0984957 Lithuania See Plans and Pricing PRODUCT NAME: NAPROXENUM + ESOMEPRAZOLUM; REGISTRATION NO/DATE: LT/1/10/2302/001-LT/1/10/2302/012 20110126
0656775 28/2000 Austria See Plans and Pricing PRODUCT NAME: BUPROPION HYDROCHLORID; NAT. REGISTRATION NO/DATE: 1-23680 20000616; FIRST REGISTRATION: NL 24160 19991201
2316456 2017C/064 Belgium See Plans and Pricing PRODUCT NAME: NALTREXONE/BUPROPION; AUTHORISATION NUMBER AND DATE: EU/1/14/988 20150330
1411900 122012000052 Germany See Plans and Pricing PRODUCT NAME: NAPROXEN MIT ESOMEPRAZOL; NAT. REGISTRATION NO/DATE: 85145.00.00 20120202; FIRST REGISTRATION: GROSSBRITANNIEN PL 17901/0263 - 0001 20101105
0984957 SPC/GB11/013 United Kingdom See Plans and Pricing PRODUCT NAME: NAPROXEN AND ESOMEPRAZOLE; REGISTERED: UK PL 17901/0263-0001 20101105
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Express Scripts
Baxter
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.